Merck & Co., Inc. Logo

Merck & Co., Inc.

A global biopharma developing innovative medicines, vaccines, and animal health products.

MRK | F

Overview

Corporate Details

ISIN(s):
DE0006599905 (+71 more)
LEI:
4YV9Y5M8S0BRK1RP0397
Country:
United States of America
Address:
126 EAST LINCOLN AVENUE, 7065 RAHWAY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Merck & Co., Inc. is a global, research-intensive biopharmaceutical company dedicated to developing innovative health solutions. With a history spanning over 130 years, the company discovers, develops, manufactures, and markets a broad range of products, including prescription medicines, vaccines, biologic therapies, and animal health products. Merck focuses on scientific innovation to address significant global health challenges, leveraging a robust research pipeline and extensive clinical trials. The company is a leader in various therapeutic areas, particularly oncology and vaccines, aiming to save and improve lives worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 14:26
Declaration of Voting Results & Voting Rights Announcements
English 80.9 KB
2025-11-24 10:50
Declaration of Voting Results & Voting Rights Announcements
English 78.5 KB
2025-11-20 14:25
Declaration of Voting Results & Voting Rights Announcements
English 78.5 KB
2025-11-17 00:00
Regulatory Filings
Q3 statement / Q3 financial report 2025
English 489.3 KB
2025-10-24 15:20
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-23 17:37
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-21 09:10
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-17 18:51
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-16 09:03
Declaration of Voting Results & Voting Rights Announcements
English 77.8 KB
2025-10-14 08:31
Declaration of Voting Results & Voting Rights Announcements
English 77.8 KB
2025-09-01 00:00
Interim / Quarterly Report
Half-yearly financial report 2025
English 999.9 KB
2025-08-13 17:39
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-08-05 23:02
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-14 15:01
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-08 18:21
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB

Automate Your Workflow. Get a real-time feed of all Merck & Co., Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Merck & Co., Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Merck & Co., Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Kalaris Therapeutics, Inc. Logo
Developing next-gen, long-acting anti-VEGF therapies for prevalent retinal diseases.
United States of America
KLRS
KalVista Pharmaceuticals, Inc. Logo
Developing oral protease inhibitors for rare diseases like hereditary angioedema (HAE).
United States of America
KALV
Kamada Ltd. Logo
Develops specialty plasma-derived therapeutics for rare and serious conditions.
Israel
KMDA
KAMADA LTD Logo
Develops specialty plasma-derived therapeutics for rare and serious diseases.
United States of America
KMDA
KANABO GROUP PLC Logo
Develops cannabis formulas and vaporization devices for the medical and consumer wellness markets.
United Kingdom
KNB
KANGSTEM BIOTECH CO., LTD. Logo
Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.
South Korea
217730
Karo Pharma AB Logo
Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.
Sweden
KARO
Karyopharm Therapeutics Inc. Logo
Develops novel oral cancer therapies by inhibiting nuclear export for hard-to-treat tumors.
United States of America
KPTI
Katakura  Industries  Co.,Ltd. Logo
Diversified company in real estate, pharmaceuticals, machinery, and textiles.
Japan
3001
KAZIA THERAPEUTICS LTD Logo
Oncology-focused drug development firm advancing anti-cancer candidates for brain cancers in trials.
United States of America
KZIA

Talk to a Data Expert

Have a question? We'll get back to you promptly.